Switch to
More onapp

How to use scorecard? Learn more

Venus Remedies Ltd

VENUSREM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹483 cr, stock is ranked 1,852
High RiskStock is 4.04x as volatile as Nifty
361.904.95 (+1.39%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹483 cr, stock is ranked 1,852
High RiskStock is 4.04x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
16.96
PB RatioPB Ratio
0.99
Dividend YieldDiv. Yield
Sector PESector PE
51.53
Sector PBSector PB
6.58
Sector Div YldSctr Div Yld
0.48%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Venus Remedies Limited is engaged in pharmaceutical product manufacturing business. The Company provides formulations and manufactures dosage injectables.

Financial TrendFinancial statements 

2021202220232024600.36608.49565.83613.0361.7640.7426.5728.50
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Notice Of Shareholders Meetings-XBRL 
Announced OnAug 21, 2024

Venus Remedies Limited has informed the Exchange about Notice of Shareholders Meeting for Annual General Meeting to be held on 23-Sep-2024 | Download

Venus Remedies Limited has informed the Exchange about Notice of Shareholders Meeting for Annual General Meeting to be held on 23-Sep-2024 | Download

Outcome of Board Meeting 
Announced OnAug 13, 2024

Venus Remedies Limited has informed the Exchange regarding Board meeting held on August 13, 2024.1. Unaudited Financial Results for the quarter ended on 30th June 2024 along with Limited review report.2. Appointed Mr. Jagdish Chander Sharma and Dr. Anil Kumar as additional Directors (Non-Executive Independent Director) of the company w.e.f. 13th August 2024 to hold office till the conclusion of next Annual General Meeting. The said appointment will be regularized for the period of 5 years subject to shareholders approval in next Annual General Meeting.3. The date of 35th Annual General Meeting as 23rd September 2024 at 11:30 a.m. (1ST) through Video Conferencing ("VC") I Other Audio-Visual Means ("OAVM").4. The books closure (Register of Members and Share Transfer Books) for the purpose of 35th Annual General Meeting will commence from 17th September 2024 to 23rd September 2024 (both days inclusive).5. The cut-off date for determining eligible shareholders for remote e-voting/ e- voting will be on September 16, 2024. Any person, who is a member of the company as on September 16, 2024, shall be entitled to vote through remote e-voting/ e- voting. The remote e-voting period commences on September 20, 2024 (9:00 a.m.) and ends on September 22, 2024 (5 :00 p.m.). | Download

Venus Remedies Limited has informed the Exchange regarding Board meeting held on August 13, 2024.1. Unaudited Financial Results for the quarter ended on 30th June 2024 along with Limited review report.2. Appointed Mr. Jagdish Chander Sharma and Dr. Anil Kumar as additional Directors (Non-Executive Independent Director) of the company w.e.f. 13th August 2024 to hold office till the conclusion of next Annual General Meeting. The said appointment will be regularized for the period of 5 years subject to shareholders approval in next Annual General Meeting.3. The date of 35th Annual General Meeting as 23rd September 2024 at 11:30 a.m. (1ST) through Video Conferencing ("VC") I Other Audio-Visual Means ("OAVM").4. The books closure (Register of Members and Share Transfer Books) for the purpose of 35th Annual General Meeting will commence from 17th September 2024 to 23rd September 2024 (both days inclusive).5. The cut-off date for determining eligible shareholders for remote e-voting/ e- voting will be on September 16, 2024. Any person, who is a member of the company as on September 16, 2024, shall be entitled to vote through remote e-voting/ e- voting. The remote e-voting period commences on September 20, 2024 (9:00 a.m.) and ends on September 22, 2024 (5 :00 p.m.). | Download

Cash Dividend 
Ex. DateSep 23, 2013

Final • Div/Share: ₹ 3

See all events